Human CYP2C19,Low-Reductase+b5
Product Specifications
UNSPSC Description
Human CYP2C19, Low-Reductase+b5, a recombinant CYP2C19, is a member of the CYP enzyme family. CYP2C19 catalyzes metabolism of xenobiotics, including some proton pump inhibitors and antiepileptic drugs[1].
Target Antigen
Cytochrome P450
Type
Enzyme
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/human-cyp2c19-low-reductase-b5.html
Smiles
[HumanCYP2C19,Low-Reductase+b5]
References & Citations
[1]Vignaux PA, et al. Human CYP2C19 Substrate and Inhibitor Characterization of Organophosphate Pesticides. Chem Res Toxicol. 2023 Sep 18;36(9):1451-1455.
Shipping Conditions
Room temperature
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742216-500 1x 500 µL
CD50 / ICAM3 (CG106), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470149-100 1x 100 µL
CD106 / VCAM1 (1.4C3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740276-500 1x 500 µL
TAG-72 / CA72.4 (B72.3), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470991-100 1x 100 µL
SOX10 (SOX10/991), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details